More from the blog
- About us
- Dementia info
- Living with dementia
- Our scientists
- Our supporters
Clinton Page from Schroders Personal Wealth talks to us about what motivates him to run two marathons this year.
Today the FDA in the US made a landmark decision to approve the Alzheimer’s drug aducanumab. The drug has been approved under the FDA’s Accelerated Approval pathway, which includes a requirement for Biogen, the pharmaceutical company that makes the drug, to conduct a further stage four clinical trial to collect evidence on its benefits to…
Today is a historic day for dementia research with the US Food and Drug Administration (FDA) announcing the first (conditional) licence of a new drug for Alzheimer’s disease in a generation.
Chrissie Wellington OBE, parkrun’s Global Lead for Health and Wellbeing, talks to us about how the reopening of parkruns can help you achieve your Think Brain Health goals.
The COVID-19 pandemic is having a huge impact on all walks of life across the UK. Everyone has been affected. Our scientists are no exception. As a result of COVID-19, 95% of researchers told us they have had projects and trials delayed because of the virus, with one in five having had research projects cancelled…
Actress Tanya Franks (EastEnders, Broadchurch, Pulling) shares her family’s experiences of Alzheimer’s disease, how she balances her work with her passion for running, and why she feels a focus on brain health is long overdue.
At Alzheimer’s Research UK, we are committed to finding treatments that slow or stop the diseases that cause dementia.
We won’t stop until we find them.
In the run up to Dementia Action Week (17-23 May 2021), Prof Alistair Burns, Professor of Old Age Psychiatry at The University of Manchester, explains why we should act now on brain health, whatever age we are.
When someone receives a diagnosis of dementia, little is known about how their condition will progress and affect that individual over time. This is because dementia affects every person differently, with a number of factors influencing progression such as having other health conditions, our level of cognitive reserve and whether a person takes medications to treat other conditions.
The onset of spring means not only lighter and longer days but also the annual Alzheimer’s Research UK Research Conference.
Although we couldn’t meet in person this year, our team worked hard to recreate the event virtually and bring together dementia researchers from all around the world.
Hilary Evans, Chief Executive of Alzheimer’s Research UK, talks to us about taking on a new challenge this spring, following the birth of her second child.
The 2021 Early Career Researcher Day demonstrates Alzheimer’s Research UK is at the forefront of dementia research allowing scientists to connect and learn from each other.
More than a quarter of us own and use a wearable device. But what if some of the data they’re collecting could help scientists identify who was in the very early stages of a disease like Alzheimer’s, even before symptoms show?
It turns out that risk genes are a really important piece of the puzzle that helps us build our understanding of how a disease progresses.
Last year Gill Livingston, professor of psychiatry of older people at UCL, led researchers from around the world on a landmark report on dementia prevention. In this post, Gill discusses her hopes for the nation’s brain health beyond the COVID-19 pandemic.
There are so many sources of information at our fingertips and new stories in the media each week claiming that different activities or foods can either cause or cure dementia. It can be difficult to know what information to pay attention to.
Despite delays in recruitment to face-to-face dementia research studies, volunteer enrolment onto studies hosted by Join Dementia Research is at an all-time high since the service launched in 2015.
Alzheimer’s Research UK recently awarded a £96,000 grant to Prof Kevin Morgan at the University of Nottingham to maintain and expand his large collection of DNA samples. This is to ensure he can continue his important research into the genetics of Alzheimer’s disease.
Prof James Rowe has joined Alzheimer’s Research UK as the Chair of our forthcoming Strategic Advisory Board.
Prof Katie Lunnon, the new Chair of our Grant Review Board, explains why we are urgently prioritising funding for early career dementia researchers.
Sometimes it feels like almost everything we do, eat and drink can affect our risk of developing a disease. The list feels endless and sometimes overwhelming. And dementia is no different.
So, we’ve answered the most common questions we get about risk!
The recent release of the documentary ‘Robin’s Wish’ shows that dementia can affect people in many ways. Sometimes more physically than the memory and thinking changes many often associate with dementia. One type that affects people differently is dementia with Lewy bodies (DLB), a condition that Oscar-winning actor Robin Williams lived with for many years.
Like so many families, Suzi Perry’s has felt the sadness and guilt that dementia causes. That’s why she’s supporting this movement to do all we can protect our brain health.
Now is a better time than ever to think about our brain health.
It won’t come as a surprise that 2020 was a challenging year for dementia research.
But scientists have been working hard to overcome the challenges, and are continuing to make discoveries that will ultimately mean more lives free from the impact of dementia.